25
Policies and Processes Policies and Processes for for Limiting Conflict of Limiting Conflict of Interest Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair, ACGIH ®

Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Embed Size (px)

Citation preview

Page 1: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Policies and ProcessesPolicies and Processes for for

Limiting Conflict of InterestLimiting Conflict of Interest

Patrick N. Breysse, PhD, CIHJohns Hopkins University

Bloomberg School of Public HealthVice-Chair, ACGIH®

Page 2: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

BackgroundBackground• Historical Perspective

– assumed membership limited to government and academics controlled conflicts of interest

– industry involvement as consultants, and as providers of data both formally and informally.

• Industry representatives could be non-voting members of ACGIH® as of 1992

• Voting rights granted in 2000

Page 3: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Background Background (cont.)(cont.)

• The OSHA proposal to re-adopt the TLVs® as PELs resulted in increased scrutiny of the TLV® process and the role of “guidelines”

• In the late 1980s and early 1990s ACGIH® was criticized as being “industry influenced” and for not limiting conflicts of interest

Page 4: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Background Background (cont.)(cont.)

• As a result of these events and other factors the ACGIH® began, in the mid-1990s, to:– Review of the TLV® process – Reevaluate of the role of industry

membership– Reevaluate conflict of interest policies and

procedures

Page 5: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

MembershipMembership

• Regular member– professional whose primary employment is

with a government agency or an educational institution

• Associate member• Student member• Retired member• Organizational member

Page 6: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Associate MemberAssociate Member• Not eligible for Regular membership

• Eligible to serve as voting members of appointive committees

• May hold elective office as a Director-at-Large on the Board of Directors, and may vote on committee matters and ACGIH® elections.

• May not vote on amendments to the Bylaws, serve as an officer on the Board of Directors, or as Chair of an appointive Committee or as a member of the Nominating Committee.

Page 7: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Conflict of Interest Policy Conflict of Interest Policy and Procedures and Procedures

DevelopmentDevelopment

• Reviewed COI policies of numerous groups• Use the National Academy of Sciences model

as the starting point• Held extensive discussions with TLV®

committee and Board of Directors• Adopted COI Policy on September 17, 2000

Page 8: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

BIAS BIAS (NAS definition)(NAS definition)

“Views stated or positions taken that are largely intellectually motivated or arise from close identification or association of an individual with a particular point of view or the positions or perspectives of a particular group.”

Page 9: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

BIASBIAS

• NAS position– Must create a committee with a balance of

potentially biasing backgrounds or professional or organizational perspectives

• TLV® Committee approach– Attempt to create a balance of opinions

and views by maintaining a diversity of professional affiliations, disciplines and activities among its membership

Page 10: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Conflict of Interest Conflict of Interest (NAS definition)(NAS definition)

“Any financial or other interest which conflicts with the service of an individual because it: (1) could impair the individual’s objectivity, or (2) could create an unfair competitive advantage for any person or organization.”

Page 11: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Conflict of InterestConflict of Interest

• Basis for Conflicts of Interest:– Employment– Financial benefit– Personal– Professional

• Avoid perceived as well as real conflict of interest

Page 12: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Conflict of InterestConflict of Interest

• Committee members serve as individuals– they do not represent organizations and/or

interest groups

• Members are selected based on expertise, soundness of judgement, and ability to contribute

Page 13: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Conflict of InterestConflict of Interest

• NAS position:– Significant conflict of interest will disqualify

an individual

• TLV® Committee approach:– Try to minimize or eliminate its effects

while allowing member to participate as fully as possible in Committee activities

Page 14: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Full d isclosure ofpossib le conflicts of

in terest

D iscussion with in fu llcom m ittee andsubcom m ittees

M anagem ent ofperceived and

real CO Is

C om m itteeand

subcom m itteechairs

Bo

ard

of

Dir

ect

ors

Ove

rsig

ht

COI Process at ACGIHCOI Process at ACGIH®®

Page 15: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Conflict of InterestConflict of Interest• Annual discussion of conflict of interest in full

committee– Definitions– Case studies

• Annual declaration by each member– Professional employment background– Current professional activities– Consulting– Research funding– Financial holdings

Page 16: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Conflict of InterestConflict of Interest

• Subcommittee– Subcommittee Chair will discuss and

remind as new substances are taken up– Subcommittee Chair will work with

individual members to minimize conflicts:• Authorship?• Co-author or external review?• Voting?

Page 17: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Conflict of InterestConflict of Interest

• It is each Member’s responsibility to ensure they have considered and addressed any conflicts

• Failure to report conflict of interest can result in immediate termination of membership on the Committee

Page 18: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

High Degree of High Degree of ConflictConflict

• Requires “direct” and substantial personal, professional and/or financial involvement with the substance

• In most cases the member should:– not author the Documentation– not participate in discussions about the

recommended TLV®

– should abstain from voting on the TLV®

• The member may discuss matters of science and express opinions about individual studies

Page 19: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

High Degree of High Degree of Conflict Conflict (cont.)(cont.)

• In some cases it may be possible for the member to participate in authorship of the Documentation as a co-author (following full discussion with and approval from the subcommittee and committee chairs)– they should not participate in drafting or

discussing the TLV® Recommendation or value, however

Page 20: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

High Degree of High Degree of Conflict ExamplesConflict Examples

• A member working with a regulatory agency who plays a role in developing regulations for the substance

• A member affiliated with an academic institution and their research forms the central basis for the TLV®

• A member who works for a company that is a major producer and who plays a direct role in the development of internal exposure levels

Page 21: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Medium Degree of Medium Degree of ConflictConflict

• Based on “indirect” and modest personal, professional and/or financial involvement with the substance

• The matter should be carefully discussed with the subcommittee chair and members and appropriate steps taken to mitigate the conflict– Typically this will mean assigning a co-author or a

reviewer for the Documentation– In some cases, abstention from voting on the TLV®

is also appropriate.

Page 22: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Medium Degree of Medium Degree of Conflict ExamplesConflict Examples

• Member who works for a regulatory agency that regulates the chemical substance, does not have a direct role in developing regulations but may be concerned with enforcing regulations

• Member who works for an academic institution and their research may be concerned with the chemical substance but is not central to the determination of a TLV®

Page 23: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Medium Degree of Medium Degree of Conflict Examples Conflict Examples (cont).(cont).

• Member employed by a company that is a major producer of the chemical substance but who plays a minor role in the internal development of exposure levels

Page 24: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Low Degree of Low Degree of ConflictConflict

• The member is affiliated with an organization that has a financial or other interest in the substance but has a very minor or nonexistent role with respect to the substance – In most cases, simply informing the

subcommittee and committee members about low level conflicts is all that is needed

Page 25: Policies and Processes for Limiting Conflict of Interest Patrick N. Breysse, PhD, CIH Johns Hopkins University Bloomberg School of Public Health Vice-Chair,

Continuing EvolutionContinuing Evolution

• The implementation of the COI Policy requires constant re-evaluation of conflicts, their impacts and management strategies

• We are learning as we go

• Developing implementation guidelines that are appropriate for each committee